Amoroso Michael
President and CEO
Amoroso Michael has filed 4 SEC Form 4 filings (9 transaction rows) across 2 companies, including DTIL, ABEO, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 19, 2026.
On the most recent filing, Amoroso Michael is listed as President and CEO at PRECISION BIOSCIENCES INC. Inside the rolling window, Amoroso Michael reported no open-market purchases and 3 open-market sales totaling $246K in DTIL. The largest disclosed transaction in the window is a sale of 34,799 DTIL shares on Jan 22, 2026, worth $145K.
Companies traded
Other insiders at DTIL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$246K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Amoroso Michael made?
Amoroso Michael has filed 4 SEC Form 4 filings (9 transaction rows) across 2 companies, including DTIL, ABEO since 2025.
Which companies does Amoroso Michael trade?
Amoroso Michael has filed SEC Form 4 disclosures for 2 companies, including DTIL, ABEO.
When was Amoroso Michael's most recent SEC Form 4 filing?
Amoroso Michael's most recent SEC Form 4 filing on Tracefour is dated Feb 19, 2026.
What is Amoroso Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Amoroso Michael is listed as President and CEO.
What is Amoroso Michael's total buy and sell value in the current window?
Inside the rolling retention window, Amoroso Michael bought $0 and sold $246K based on SEC Form 4 filings.
What was Amoroso Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,799 DTIL shares on 2026-01-22, worth $145K, per SEC Form 4 filings.